Correlation Between Health Care and Pharmaceuticals Ultrasector

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Health Care and Pharmaceuticals Ultrasector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Health Care and Pharmaceuticals Ultrasector into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Health Care Ultrasector and Pharmaceuticals Ultrasector Profund, you can compare the effects of market volatilities on Health Care and Pharmaceuticals Ultrasector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Health Care with a short position of Pharmaceuticals Ultrasector. Check out your portfolio center. Please also check ongoing floating volatility patterns of Health Care and Pharmaceuticals Ultrasector.

Diversification Opportunities for Health Care and Pharmaceuticals Ultrasector

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Health and Pharmaceuticals is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Health Care Ultrasector and Pharmaceuticals Ultrasector Pr in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pharmaceuticals Ultrasector and Health Care is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Health Care Ultrasector are associated (or correlated) with Pharmaceuticals Ultrasector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pharmaceuticals Ultrasector has no effect on the direction of Health Care i.e., Health Care and Pharmaceuticals Ultrasector go up and down completely randomly.

Pair Corralation between Health Care and Pharmaceuticals Ultrasector

Assuming the 90 days horizon Health Care Ultrasector is expected to generate 0.69 times more return on investment than Pharmaceuticals Ultrasector. However, Health Care Ultrasector is 1.45 times less risky than Pharmaceuticals Ultrasector. It trades about 0.01 of its potential returns per unit of risk. Pharmaceuticals Ultrasector Profund is currently generating about 0.01 per unit of risk. If you would invest  10,494  in Health Care Ultrasector on September 1, 2024 and sell it today you would earn a total of  432.00  from holding Health Care Ultrasector or generate 4.12% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Health Care Ultrasector  vs.  Pharmaceuticals Ultrasector Pr

 Performance 
       Timeline  
Health Care Ultrasector 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Health Care Ultrasector has generated negative risk-adjusted returns adding no value to fund investors. In spite of latest weak performance, the Fund's forward indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the fund investors.
Pharmaceuticals Ultrasector 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Pharmaceuticals Ultrasector Profund are ranked lower than 6 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly weak forward indicators, Pharmaceuticals Ultrasector may actually be approaching a critical reversion point that can send shares even higher in December 2024.

Health Care and Pharmaceuticals Ultrasector Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Health Care and Pharmaceuticals Ultrasector

The main advantage of trading using opposite Health Care and Pharmaceuticals Ultrasector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Health Care position performs unexpectedly, Pharmaceuticals Ultrasector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pharmaceuticals Ultrasector will offset losses from the drop in Pharmaceuticals Ultrasector's long position.
The idea behind Health Care Ultrasector and Pharmaceuticals Ultrasector Profund pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years